RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Accessory Gene Regulator Group Polymorphisms in Methicillin-Resistant Staphylococcus aureus: An Association with Clinical Significance

      한글로보기

      https://www.riss.kr/link?id=A101617472

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Purpose: Virulent gene expression in Staphylococcus aureus is controlled by regulators such as the accessory gene regulator (agr). Strains can be divided into four major agr groups (agr I-IV) on the basis of agrD and agrC polymorphisms. The purpose of this study was to define the proportion of agr I, II, and III polymorphisms and to compare the clinical characteristics between group I and non-group I polymorphisms of methicillin-resistant Staphylococcus aureus (MRSA) strains in a Korean tertiary care teaching hospital. Materials and Methods: A total of 158 clinical isolates were evaluated by RFLPs (restriction fragment length polymorphisms). Results: The mean age of the patients was 50.2±21.9 years old. There were 74 (49.3%), 66 (44.0%), 10 (6.7%), 7 (4.4%), and 1 (0.6%) strains in agr group I, II, III, I+II, and I+III polymorphisms, respectively. Only ear infections were a statistically significant clinical parameter according to univariate (p=0.001) and multivariate analysis (OR, 4.721 (1.273-17.508), p=0.020). Conclusion: This study suggests that agr group I is the most prevalent in Korea, and ear infections are correlated with the group I polymorphism, which is a different clinical trend from western countries. It can also be inferred that community-acquired MRSA correlates with agr group I.
      번역하기

      Purpose: Virulent gene expression in Staphylococcus aureus is controlled by regulators such as the accessory gene regulator (agr). Strains can be divided into four major agr groups (agr I-IV) on the basis of agrD and agrC polymorphisms. The purpose of...

      Purpose: Virulent gene expression in Staphylococcus aureus is controlled by regulators such as the accessory gene regulator (agr). Strains can be divided into four major agr groups (agr I-IV) on the basis of agrD and agrC polymorphisms. The purpose of this study was to define the proportion of agr I, II, and III polymorphisms and to compare the clinical characteristics between group I and non-group I polymorphisms of methicillin-resistant Staphylococcus aureus (MRSA) strains in a Korean tertiary care teaching hospital. Materials and Methods: A total of 158 clinical isolates were evaluated by RFLPs (restriction fragment length polymorphisms). Results: The mean age of the patients was 50.2±21.9 years old. There were 74 (49.3%), 66 (44.0%), 10 (6.7%), 7 (4.4%), and 1 (0.6%) strains in agr group I, II, III, I+II, and I+III polymorphisms, respectively. Only ear infections were a statistically significant clinical parameter according to univariate (p=0.001) and multivariate analysis (OR, 4.721 (1.273-17.508), p=0.020). Conclusion: This study suggests that agr group I is the most prevalent in Korea, and ear infections are correlated with the group I polymorphism, which is a different clinical trend from western countries. It can also be inferred that community-acquired MRSA correlates with agr group I.

      더보기

      참고문헌 (Reference)

      1 "controls Staphylococcus aureus virulence in a murine arthritis model" 3879-85, infectimmun1993;61

      2 "and sequencing of an accessory gene regulator" 4365-72, jbacteriol1988;170

      3 "What is a pathogen?" 63 : 359-365, 1997

      4 "Transcriptional control of the agr-dependent virulence gene regulator, RNA III, in Staphylococcus aureus" 21 : 1227-1237, 1996

      5 "Toxin involvement in staphylococcal scalded skin syndrome" 25 : 1369-1373, 1997

      6 "The molecular basis of pathogenicity" New York, N.Y.: Churchill Livingstone 55-81, 1997

      7 "Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule" 3967-75, emboj1993;12

      8 "Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence" 96 : 1218-1223, 1999

      9 "Staphylococcus and Micrococcus" Washington, DC: ASM Press 282-298, 1995

      10 "Staphylococcal toxins in human disease" arbuth (arbuth): -7,

      1 "controls Staphylococcus aureus virulence in a murine arthritis model" 3879-85, infectimmun1993;61

      2 "and sequencing of an accessory gene regulator" 4365-72, jbacteriol1988;170

      3 "What is a pathogen?" 63 : 359-365, 1997

      4 "Transcriptional control of the agr-dependent virulence gene regulator, RNA III, in Staphylococcus aureus" 21 : 1227-1237, 1996

      5 "Toxin involvement in staphylococcal scalded skin syndrome" 25 : 1369-1373, 1997

      6 "The molecular basis of pathogenicity" New York, N.Y.: Churchill Livingstone 55-81, 1997

      7 "Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule" 3967-75, emboj1993;12

      8 "Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence" 96 : 1218-1223, 1999

      9 "Staphylococcus and Micrococcus" Washington, DC: ASM Press 282-298, 1995

      10 "Staphylococcal toxins in human disease" arbuth (arbuth): -7,

      11 "Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses" 251-72, critrevmicrobiol1990;17

      12 "Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis" 65 : 1550-1556, 1997

      13 "Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis" 63 : 3373-3380, 1995

      14 "Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease" 70 : 631-641, 2002

      15 "Regulation of pathogenicity in Staphylococcus aureus by a peptide-based density-sensing system" Washington, DC: ASM Press 129-146, 1999

      16 "Regulation of exoprotein gene expression in Staphylococcus aureus by agar" 58-61,

      17 "Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide" 182 : 5721-5729, 2000

      18 "Performance standards for antimicrobial susceptibility testing: twelfth informational supplement [M100-S12]" Wayne, PA: NCCLS 2002

      19 "Pathogenicity factors and their regulation" Washington, DC: ASM Press 392-407, 2000

      20 "Molecular analysis of the accessory gene regulator (agr) locus and balance of virulence factor expression in epidemic methicillin-resistant Staphylococcus aureus" 181 : 990-1000, 2000

      21 "Longer-term diabetic patients have a more frequent incidence of nosocomial infections after elective gastrectomy" 91 : 1176-1181, 2000

      22 "Intraspecies variation in bacterial genomes: the need for a species genome concept" 8 : 396-401, 2000

      23 "Infections caused by staphylococci" -11, infection1983;11

      24 "Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus" 182 : 6517-6522, 2000

      25 "Evaluation of intraspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization" 188 : 250-256, 2003

      26 "Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis" jclininvest1994;941815-22

      27 "Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin" 35 : 819-824, 2002

      28 "Community-acquired MRSA: the Australian experience [abstract 359]. In: Program and abstracts of the 10th International Symposium on Staphylococci and Staphylococcal Diseases (Tsukuba, Japan)" Japan: Japan Symposium on Staphylococci and Staphylococcal Diseases 18-, 2002

      29 "Community-acquired MRSA: the American experience [abstract 352]. In: Program and abstracts of the 10th International Symposium on Staphylococci and Staphylococcal Diseases (Tsukuba, Japan)" Japan: Japan Symposium on Staphylococci and Staphylococcal Diseases 19-, 2002

      30 "Community- acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk" 279 : 593-598, 1998

      31 "Biofilm formation by and accessory gene regulator typing of methicillin-resistant Staphylococcus aureus strains recovered from patients with nosocomial infections" 27 : 188-190, 2006

      32 "Bacterial interference caused by autoinducing peptide variants" 276 : 2027-2030, 1997

      33 "Analysis of the genetic variability of virulence-related loci in epidemic clones of methicillin-resistant Staphylococcus aureus" 49 : 366-379, 2005

      34 "Accessory gene regulator group II polymorphism in methicillin- resistant Staphylococcus aureus is predictive of failure of vancomycin therapy" 38 : 1700-1705, 2004

      35 "Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin" 46 : 1492-1502, 2002

      36 "A study of nosocomial infection in relation to different host factors in an Indian teaching hospital" 115 : 244-246, 1995

      37 "1996 national nosocomial infection surveillance in Korea" 2 : 157-176, 1997

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼